Cite
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
MLA
Gil Jimenez, A.(author), et al. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-Based Neoadjuvant Chemotherapy in Bladder Cancer. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1398448132&authtype=sso&custid=ns315887.
APA
Gil Jimenez, A. (author), van Dorp, J. (author), Contreras-Sanz, A. (author), van der Vos, K. (author), Vis, D. J. (author), Braaf, L. (author), Broeks, A. (author), Kerkhoven, R. (author), van Kessel, K. E. M. (author), & Wessels, L. F. A. (author). (2023). Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
Chicago
Gil Jimenez, A. (author), Jeroen (author) van Dorp, Alberto (author) Contreras-Sanz, Kristan (author) van der Vos, Daniel J. (author) Vis, Linde (author) Braaf, Annegien (author) Broeks, Ron (author) Kerkhoven, Kim E.M. (author) van Kessel, and L.F.A. (author) Wessels. 2023. “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-Based Neoadjuvant Chemotherapy in Bladder Cancer.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1398448132&authtype=sso&custid=ns315887.